A lung adenocarcinoma patient with co-mutations of MET and EGFR exon20 insertion responded to crizotinib

被引：0
作者：
Yan Chen
Bo Jiang
Yuange He
Chu Zhang
Wenjie Zhou
Cheng Fang
Dejian Gu
Minxia Zhang
Mei Ji
Juntao Shi
Xin Yang
机构：
[1] The Third Affiliated Hospital of Soochow University,Department of Oncology
[2] The First People’s Hospital of Changzhou,Department of Thoracic Surgery
[3] The Third Affiliated Hospital of Soochow University,Geneplus
[4] The First People’s Hospital of Changzhou,Beijing, 9th Floor
[5] No.6 Building,Department of Cardiothoracic Surgery
[6] Peking University Medical Industrial Park,undefined
[7] The Third Affiliated Hospital of Soochow University,undefined
[8] The First People’s Hospital of Changzhou,undefined
来源：
BMC Medical Genomics | / 15卷
关键词：
NCSLC; mutation; mutation; Double mutation; Crizotinib;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 159 条
  • [1] Doroshow DB(2018)Treatment of advanced non-small cell lung cancer in 2018 JAMA Oncol 4 569-570
  • [2] Herbst RS(2018)Immune checkpoint inhibitors in cancer therapy: a focus on T-regulatory cells Immunol Cell Biol 96 21-33
  • [3] Sasidharan Nair V(2019)Mechanisms regulating PD-L1 expression on tumor and immune cells J Immunother Cancer 7 305-454
  • [4] Elkord E(2018)The biology and management of non-small cell lung cancer Nature 553 446-1019
  • [5] Chen S(2012)Activity and safety of crizotinib in patients with ALK-positive non-small-cell lung cancer: updated results from a phase 1 study Lancet Oncol 13 1011-1991
  • [6] Crabill GA(2019)Crizotinib in c-MET- or ROS1-positive NSCLC: results of the AcSe phase II trial Ann Oncol 30 1985-1064
  • [7] Pritchard TS(2017)Coexistence of MET exon 14 mutations with EGFR mutations in non-small cell lung cancer J Clin Oncol 35 e20636-486
  • [8] McMiller TL(2019)The correlations of tumor mutational burden among single-region tissue, multi-region tissues and blood in non-small cell lung cancer J Immunother Cancer 7 98-229
  • [9] Wei P(2019)Prevalence of recurrent oncogenic fusion in mismatch repair-deficient colorectal carcinoma with hypermethylated MLH1 and wild-type BRAF and KRAS Modern Pathol 32 1053-730
  • [10] Pardoll DM(2016)MET exon 14 skipping in non-small cell lung cancer Oncologist 21 481-849
12345678910